関連する実験動画
Updated: May 7, 2026

07:46
Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
Published on: October 16, 2010
アンジオスタチン: 内皮に依存した血管拡張の負の調節剤
Ryoji Koshida1, Jingsong Ou, Toshiro Matsunaga
1Department of Physiology, and Pharmacology & Toxicology, Medical College of Wisconsin, Milwaukee 53226, USA.
Circulation
|February 20, 2003
まとめ
アンジオスタチンは,内皮酸化窒素合成酵素 (eNOS) 機能に影響することで血管の拡張を阻害し,スーパーオキシドの産生を増加させます. このメカニズムは,アンジオスタチンの抗血管新生効果に寄与する.
科学分野:
- 内皮細胞の生物学
- 血管生理学 血管の生理学
- 内皮機能の分子メカニズム
背景:
- アンジオスタチンは,血管新生を阻害することが知られている.
- 内皮機能には,血管拡張,酸化窒素 (NO) 生成,および超酸化窒素アニオン (O2-) 生成が含まれます.
- 熱ショックタンパク質90 (hsp90) は,酸化窒素合成酵素 (NOS) の活性調節に関与しています.
研究 の 目的:
- 血管拡張に対するアンジオスタチンの効果を調査する.
- アンジオスタチンのメカニズムにおけるhsp90-eNOS関連性の役割を調べる.
- 内皮中の酸化窒素 (NO) と超酸化窒素アニオン (O2-) の生成に対するアンジオスタチンの影響を決定する.
主な方法:
- アセチルコリン (ACh),血管内皮成長因子 (VEGF),パパベリンへの反応として血管拡張を評価するためのビデオ顕微鏡検査.
- ラットの大動脈と牛の大動脈内皮細胞 (BAECs) のhsp90-eNOS関連性を決定するために,西側ブロッティングまたは共免疫プレシピテーション.
- 化学発光とスペクトロフォトメトリックアッセイを用いたBAECにおけるNOとO2生成の測定.
主要な成果:
- アンジオスタチンはACHおよびVEGF媒介の血管拡張を著しく低下させましたが,パパベリン誘発の血管拡張はそうではありませんでした.
- ポリエチレン・グリコレイテッド・スーパーオキシド・ディスミュータゼ (PEG-SOD) 治療は血管拡張を改善し,スーパーオキシドの役割を示唆しました.
- アンジオスタチンは,hsp90-eNOS関連性を減少させ,BAECにおけるL-NAME抑制可能なO2生成を増加させた.
結論:
- アンジオスタチンは,内皮酸化窒素合成酵素 (eNOS) の機能を変化させ,活性化時にO2生成を促進します.
- このeNOS活動の変化は,内皮に依存した血管拡張の障害に寄与する.
- この発見は,アンジオスタチンの抗血管新生特性に関するメカニズム的な洞察を提供します.
関連する概念動画
Allosteric Regulation
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Nitric Oxide Signaling Pathway
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
Autoregulation of Blood Flow
Autoregulation mechanisms are characterized by their inherent capacity for self-regulation without necessitating specific nervous stimulation or endocrine control. These mechanisms facilitate the adjustment of blood flow and, therefore, perfusion specific to each tissue region. This self-regulation encompasses chemical signals and myogenic controls.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation.

